Publications

We do ask that you acknowledge BMC2 as the source whenever using or referencing our materials in any format, written or otherwise, including but not limited to print and digital publications, presentations, grant applications, and websites. This applies to both original and derivative works. To properly cite BMC2:

Please acknowledge "BMC2."
If the material was obtained on our website, include a link to the source page.
If the material was not obtained on our website, include a link to bmc2.org.
Include required disclaimer language. This language - and additional resources for collaborators including, fonts, logos, templates, and helpful tips - can be found on our "Brand and Style Guide" page.

Publications

Results

The Changing Definition of Contrast Induced Nephropathy and Its Clinical Implications: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

Cause and Circumstance of In-Hospital Mortality Among Patients Undergoing Contemporary Percutaneous Coronary Intervention: A Root-Cause Analysis

Contemporary use and effectiveness of N-Acetylcysteine in preventing contrast-induced nephropathy among patients undergoing percutaneous coronary intervention

Outcome of contemporary percutaneous coronary intervention in the elderly and the very elderly; Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2), Clinical Cardiology

Renal function based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions

Safety of Contemporary Percutaneous Peripheral Arterial Interventions in the Elderly Insights From the BMC2 PVI (Blue Cross Blue Shield of Michigan Cardiovascular Consortium Peripheral Vascular Intervention) Registry

Complication Rates for Percutaneous Lower Extremity Arterial Antegrade Access

Trends and Disparities in Referral to Cardiac Rehabilitation After Percutaneous Coronary Intervention

The Association of Sex with Outcomes Among Patients Undergoing Primary PCI for STEMI In The Contemporary Era: Insights From The Blue Cross Blue Shield Of Michigan Cardiovascular Consortium (BMC2)